Title: Talented Researcher Marco Fiorillo Returns to University of Calabria, Developing Innovative Lung Cancer Therapies
After eight years of doctoral research in Manchester and Salford, 38-year-old Marco Fiorillo has returned to his alma mater, the University of Calabria (Unical). This ‘brain gain’ is a testament to Unical’s efforts to attract back global talent through strategic recruitment policies.
Fiorillo, now a docent and researcher in Biochimica at the Department of Pharmacy and Health and Nutritional Sciences, is making waves with his research on a specific type of lung cancer. He has identified a vulnerability that could pave the way for novel therapies.
Targeting Cancer’s Energy Source
Fiorillo’s work centers around the mitochondria, tiny cellular organelles that facilitate cell respiration. However, they also enable the survival of dangerous cancer stem cells that resist conventional treatments. In collaboration with Greek and British researchers, Fiorillo has shown that certain compounds can reduce mitochondrial functionality in cancer cells without harming healthy cells. These promising agents could combat advanced, treatment-resistant tumors and prevent metastasis.
Overcoming Genetic Resistance
Fiorillo’s focus lies in mutations to the LKB1 oncosuppressor gene, which significantly alters cellular metabolism and makes tumors resistant to standard therapies. He has developed two new compounds that selectively target these mutated cancer cells. Currently in preclinical testing, these compounds are being evaluated for safety and efficacy before human trials.
The Future of Cancer Treatment
Fiorillo’s work aligns with the burgeoning field of precision oncology, which tailors treatments to individual genetic profiles. His return to Unical underscores the institution’s commitment to fostering excellence and attracting top talent.
A Message to Young Students
In an interview with LaCTv’s ‘Dentro la Notizia,’ Fiorillo encouraged young students to seize the opportunities offered by Unical and pursue their passions. His inspiring journey serves as a beacon for aspiring researchers, proving that with dedication and perseverance, one can make a significant impact in the field of cancer research.
